Product Description
This digital document is an article from Journal of Neuroscience Nursing, published by American Association of Neuroscience Nurses on June 1, 1998. The length of the article is 7464 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.From the supplier: Early treatment of ischemic stroke may include neuroprotective agents and thrombolytic drugs to reduce the extent of neuronal damage. Neuroprotective agents under investigation block the glutamate cascade, inhibit calcium flux, antagonize opioid receptors, or block nitric oxide formation or free radical activity. Thrombolytics, such as streptokinase, urokinase, and tissue plasminogen activator, can dissolve cerebral blood clots, but raise the risk of intracerebral hemorrhage.Citation DetailsTitle: Neuroprotective and thrombolytic agents: advances in stroke treatment.Author: Nanette HockPublication: Journal of Neuroscience Nursing (Refereed)Date: June 1, 1998Publisher: American Association of Neuroscience NursesVolume: v30 Issue: n3 Page: p175(10)Distributed by Thomson Gale